supp.fit

Valerian

7 benefits mapped to clinical evidence across supplements.

Dose per serving from products

361 products in our catalogue print how much Valerian a serving holds.

Most common: 250 mg to 500 mg, 18% of 361 products.

Dose per servingProducts
2.5 mg or less
5
2.5 mg to 5 mg
14
5 mg to 10 mg
4
10 mg to 25 mg
26
25 mg to 50 mg
61
50 mg to 100 mg
46
100 mg to 250 mg
64
250 mg to 500 mg
65
500 mg to 1 g
49
1 g to 2.5 g
27

Dose per serving from research

22 study groups in 21 studies say how much Valerian participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 36% of 22 study groups.

Daily doseStudy groups
100 mg or less
1
100 mg to 250 mg
3
250 mg to 500 mg
6
500 mg to 1 g
8
1 g to 2.5 g
4

See every study group

Commonly used together

8 of 22 study groups took Valerian with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Hops
4

Benefit Evidence

Sleep quality + latency

Deep sleep + duration

Anxiety/stress eased

2,121 people

Stress/anxiety ↓

Sleep ↑, anxiety ↓

1,247 people
Relaxation
Moderate

Anxiety/stress ↓

Sleep/relaxation ↑

1,228 people
Alertness
Moderate

Alertness: - first hours

Alertness: no next-day

593 people
Sleep onset
Moderate

Latency ↓ ~49%

Duration/Efficiency ↑

409 people
Mood balance
Moderate

Anxiety, stress ↓

Sleep, wellbeing ↑

913 people

Anxiety/stress ↓

Sleep/anxiety ↓

743 people

Research sources

Sleep quality (19)
  1. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study

    PubMed ID: 12568976

    Large multicenter trial: 600 mg/day valerian produced clinically meaningful sleep-quality improvements vs active comparator.

  2. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)

    PubMed ID: 21399726

    Large cancer RCT: primary PSQI AUC negative, but secondary/week‑4 measures showed increased sleep with valerian.

  3. Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial

    PubMed ID: 21775910

    Triple‑blind RCT (n=100) reported a clinically meaningful increase in proportion with improved PSQI sleep quality vs placebo.

  4. The effectiveness of valerian acupressure on the sleep of ICU patients: a randomized clinical trial

    PubMed ID: 22391336

    ICU study explicitly reported decreased night wake frequency after 'valerian acupressure' intervention.

  5. Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial

    PubMed ID: 28478716

    Randomized trial in patients starting efavirenz showed significant improvements in sleep and anxiety with nightly valerian.

  6. Valerian extract alters functional brain connectivity: A randomized double-blind placebo-controlled trial

    PubMed ID: 30632220

    EEG connectivity changes correlated with anxiolysis, implying decreased cognitive agitation even if self‑reported anxiety fell in both groups.

  7. Efficacy of Valerian Extract on Sleep Quality after Coronary Artery bypass Graft Surgery: A Triple-Blind Randomized Controlled Trial

    PubMed ID: 33420602

    Triple‑blind RCT after CABG showed significant PSQI and objective sleep improvements with valerian.

  8. Valerian/lemon balm use for sleep disorders during menopause

    PubMed ID: 24199972

    Randomized trial in menopausal women: valerian+lemon balm significantly reduced PSQI scores vs placebo (combination product).

  9. The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism

    PubMed ID: 15254851

    Blocking caffeine‑induced EEG arousal indicates the formulation can reduce physiologic agitation.

  10. [Vigilance-decreasing effects of 2 plant-derived sedatives]

    PubMed ID: 8657986

    Large controlled study reported improved subjective sleep quality after valerian-containing remedies.

  11. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial

    PubMed ID: 16335333

    Valerian+hops tablet produced small subjective sleep improvements in a large RCT.

  12. Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms

    PubMed ID: 18559301

    Acute valerian+hops fluid extract increased EEG measures of deeper sleep vs placebo.

  13. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial

    PubMed ID: 23543804

    Polyherbal (valerian+passionflower+hops) RCT performed comparably to zolpidem on sleep duration/latency (multi‑ingredient).

  14. A Randomized, Double-Blind, Placebo-Controlled Decentralized Trial to Assess Sleep, Health Outcomes, and Overall Well-Being in Healthy Adults Reporting Disturbed Sleep, Taking a Melatonin-Free Supplement

    PubMed ID: 37686820

    Large decentralized RCT of a botanical blend higher in valerian/hops/GABA improved PROMIS sleep disturbance (multi‑ingredient).

  15. Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial

    PubMed ID: 40462685

    Valerian+hops increased total sleep duration and Fitbit sleep score, consistent with increased perceived/recorded sleep depth.

  16. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study

    PubMed ID: 37899385

    Large 8‑week RCT with objective (actigraphy/PSG) and PSQI improvements showing robust sleep‑quality gains with standardized valerian.

  17. Effects of Passiflora incarnata and Valeriana officinalis in the control of anxiety due to tooth extraction: a randomized controlled clinical trial

    PubMed ID: 38743126

    Valerian (with passionflower) reduced state anxiety during dental procedures—supports utility for acute agitation, including pre‑bed.

  18. [Medicinal baths for treatment of generalized fibromyalgia]

    PubMed ID: 10352370

    Valerian baths improved patients' reported sleep and well‑being in a small randomized study.

  19. [Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study]

    PubMed ID: 10899744

    Randomized trial found valerian improved sleep quality comparably to oxazepam.

Stress & Anxiety (12)
  1. Effects of Passiflora incarnata and Valeriana officinalis in the control of anxiety due to tooth extraction: a randomized controlled clinical trial

    PubMed ID: 38743126

    Valerian (with passionflower) before molar extraction lowered state anxiety vs placebo in a triple‑blind RCT.

  2. Efficacy of Valerian Extract on Sleep Quality after Coronary Artery bypass Graft Surgery: A Triple-Blind Randomized Controlled Trial

    PubMed ID: 33420602

    Post‑CABG valerian improved sleep latency/duration/efficiency, suggesting reduced restlessness overnight.

  3. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study

    PubMed ID: 37899385

    Standardized valerian increased sleep efficiency and total sleep time, which commonly reflect reduced nocturnal restlessness.

  4. Valerian extract alters functional brain connectivity: A randomized double-blind placebo-controlled trial

    PubMed ID: 30632220

    Valerian produced EEG connectivity changes linked to anxiolysis, consistent with easing nervous tension physiologically.

  5. Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial

    PubMed ID: 28478716

    Valerian nightly significantly improved anxiety scores in people initiating efavirenz.

  6. The effectiveness of valerian acupressure on the sleep of ICU patients: a randomized clinical trial

    PubMed ID: 22391336

    Valerian acupressure in ICU reduced night wake frequency and increased total sleep time (fewer nocturnal interruptions implied).

  7. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?

    PubMed ID: 19284179

    In RLS patients who were sleepy at baseline, 800 mg valerian reduced RLS symptom severity (reduced restlessness).

  8. Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial

    PubMed ID: 40462685

    Valerian+hops increased nightly sleep time; increased continuity implies less restlessness (small RCT).

  9. A Randomized, Double-Blind, Placebo-Controlled Decentralized Trial to Assess Sleep, Health Outcomes, and Overall Well-Being in Healthy Adults Reporting Disturbed Sleep, Taking a Melatonin-Free Supplement

    PubMed ID: 37686820

    Large real‑world RCT of a botanical blend higher in valerian reported reductions in anxiety and stress (multi‑ingredient).

  10. The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism

    PubMed ID: 15254851

    Valerian+hops extract reduced caffeine‑induced EEG arousal, demonstrating central calming/adenosine‑related activity.

  11. Comparison the effect of valerian and gabapentin on RLS and sleep quality in hemodialysis patients: A randomized clinical trial

    PubMed ID: 37039703

    Crossover trial in hemodialysis patients: valerian helped sleep quality though gabapentin was superior for RLS—valerian provided modest benefit.

  12. Effects of a fixed herbal drug combination (Ze 185) to an experimental acute stress setting in healthy men - An explorative randomized placebo-controlled double-blind study

    PubMed ID: 29433687

    Four‑day multi‑herb product including valerian reduced subjective anxiety during an acute stress test.

Relaxation (11)
  1. The effectiveness of valerian acupressure on the sleep of ICU patients: a randomized clinical trial

    PubMed ID: 22391336

    The intervention combined valerian with acupressure/aromatherapy as a bedside ritual and produced immediate relaxation and sleep benefits in ICU patients.

  2. Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial

    PubMed ID: 28478716

    Significant reductions in anxiety were observed in a randomized trial with nightly valerian.

  3. Valerian extract alters functional brain connectivity: A randomized double-blind placebo-controlled trial

    PubMed ID: 30632220

    Valerian altered EEG connectivity in ways correlated with reduced anxiety—physiologic evidence supporting relaxation.

  4. A Randomized, Double-Blind, Placebo-Controlled Decentralized Trial to Assess Sleep, Health Outcomes, and Overall Well-Being in Healthy Adults Reporting Disturbed Sleep, Taking a Melatonin-Free Supplement

    PubMed ID: 37686820

    Large trial of a sleep‑targeted botanical blend (including valerian) improved subjective sleep and wellbeing when used as a nightly formulation.

  5. [Medicinal baths for treatment of generalized fibromyalgia]

    PubMed ID: 10352370

    Valerian added to whirl baths improved sleep and well‑being—strong link to enhancing a relaxation ritual (bath).

  6. Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial

    PubMed ID: 21775910

    Valerian extract (530 mg BID) produced notable sleep‑quality improvements in postmenopausal women, supporting pre‑bed use.

  7. Effects of Passiflora incarnata and Valeriana officinalis in the control of anxiety due to tooth extraction: a randomized controlled clinical trial

    PubMed ID: 38743126

    Peri‑procedural administration lowered state anxiety, indicating acute relaxation effects in stressful settings.

  8. Effects of a fixed herbal drug combination (Ze 185) to an experimental acute stress setting in healthy men - An explorative randomized placebo-controlled double-blind study

    PubMed ID: 29433687

    Short multi‑herb regimen reduced subjective anxiety during stress testing.

  9. The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism

    PubMed ID: 15254851

    Valerian+hops reduced EEG markers of arousal (pharmacodynamic evidence for CNS relaxation).

  10. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study

    PubMed ID: 37899385

    Sustained nightly dosing led to improved latency and sleep quality, consistent with efficacy when used to unwind pre‑bed.

  11. Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial

    PubMed ID: 40462685

    Valerian+hops nightly increased sleep time and sleep score, compatible with facilitating pre‑sleep unwinding.

Alertness (6)
  1. Effects of a Valerian-Hops Extract Combination (Ze 91019) on Sleep Duration and Daytime Cognitive and Psychological Parameters in Occasional Insomnia: A Randomized Controlled Feasibility Trial

    PubMed ID: 40462685

    Increased nightly sleep duration without next‑day cognitive harm suggests participants could wake more refreshed.

  2. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study

    PubMed ID: 12568976

    Large trial reported improvements on SF‑B subscales related to refreshment and psychic symptoms with valerian.

  3. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)

    PubMed ID: 21399726

    Valerian arm showed improved fatigue scores in cancer patients, suggesting enhanced morning alertness/less morning sleepiness.

  4. Efficacy of Valerian Extract on Sleep Quality after Coronary Artery bypass Graft Surgery: A Triple-Blind Randomized Controlled Trial

    PubMed ID: 33420602

    Post‑CABG improvements in sleep parameters without safety concerns suggest better morning functioning.

  5. [Vigilance-decreasing effects of 2 plant-derived sedatives]

    PubMed ID: 8657986

    Subjects reported improved subjective sleep and there was no evidence of next‑morning hangover.

  6. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study

    PubMed ID: 37899385

    Objective sleep improvements (more TST/efficiency) predict better morning restoration and subjective sleep quality improvements were seen.

Sleep onset (6)
  1. The effectiveness of valerian acupressure on the sleep of ICU patients: a randomized clinical trial

    PubMed ID: 22391336

    Valerian delivered as part of an acupressure/aromatherapy bedside routine produced immediate sleepiness/relaxation in ICU—supports ritualized use.

  2. [Medicinal baths for treatment of generalized fibromyalgia]

    PubMed ID: 10352370

    Valerian used in a therapeutic bath improved sleep/well‑being—strong example of integrating valerian into a bedtime ritual.

  3. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study

    PubMed ID: 37899385

    Actigraphy showed a large reduction in sleep latency (≈48 min) at Day 56 versus placebo in an 8‑week RCT with standardized valerian.

  4. Efficacy of Valerian Extract on Sleep Quality after Coronary Artery bypass Graft Surgery: A Triple-Blind Randomized Controlled Trial

    PubMed ID: 33420602

    Post‑CABG RCT reported significant decreases in sleep latency with valerian over 30 days.

  5. Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial

    PubMed ID: 28478716

    Valerian improved sleep in efavirenz patients, though latency was not the primary reported metric—supports modest impact on sleep onset.

  6. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial

    PubMed ID: 23543804

    Polyherbal (valerian+passionflower+hops) performed similarly to zolpidem for sleep latency over 2 weeks (multi‑ingredient).

Mood balance (4)
  1. A Randomized, Double-Blind, Placebo-Controlled Decentralized Trial to Assess Sleep, Health Outcomes, and Overall Well-Being in Healthy Adults Reporting Disturbed Sleep, Taking a Melatonin-Free Supplement

    PubMed ID: 37686820

    Large botanical blend with higher valerian content improved anxiety and wellbeing in a decentralized RCT (multi‑ingredient).

  2. Fixed herbal drug combination with and without butterbur (Ze 185) for the treatment of patients with somatoform disorders: randomized, placebo-controlled pharmaco-clinical trial

    PubMed ID: 19274698

    Four‑herb combo including valerian improved anxiety and depression vs placebo in an RCT, but attribution to valerian alone is limited.

  3. [Clinical study on compound prescription with Valerianae Jatamansi Rhizoma et Radix in treatment of generalized anxiety disorder]

    PubMed ID: 29493163

    Valerian‑containing prescription improved GAD symptoms and salivary cortisol similar to control over 4 weeks (compound formula).

  4. Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial

    PubMed ID: 28478716

    Valerian reduced anxiety in a randomized trial; anxiety reduction contributes to mood calming.

Stress resilience (3)
  1. Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial

    PubMed ID: 28478716

    Valerian reduced anxiety in patients initiating efavirenz, relevant to stress mitigation in a clinical context.

  2. A Randomized, Double-Blind, Placebo-Controlled Decentralized Trial to Assess Sleep, Health Outcomes, and Overall Well-Being in Healthy Adults Reporting Disturbed Sleep, Taking a Melatonin-Free Supplement

    PubMed ID: 37686820

    Large decentralized trial reported reductions in anxiety and stress for the valerian‑containing botanical formulation.

  3. Effects of a fixed herbal drug combination (Ze 185) to an experimental acute stress setting in healthy men - An explorative randomized placebo-controlled double-blind study

    PubMed ID: 29433687

    Herbal prescription containing valerian improved anxiety and salivary cortisol similarly to control in GAD patients (compound formulation).

Similar by evidence

Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.

Products with Valerian

Search all

1027 products whose verified label declares Valerian — not every bottle that mentions it in a title.